Lucane Pharma is a company based in France that is specialized in the development and commercialization of medicinal products targeting rare disorders. The company was established in 2009 with a clear mission to provide patients with a real improvement in the management of their disease. This includes developing new products for diseases currently lacking effective treatment, improving formulations of existing products, and introducing new presentations fulfilling specific needs. Lucane Pharma operates within the pharmaceutical and marketing industries, leveraging its expertise to address unmet medical needs. As of now, there is no information available regarding the company's last investment or the associated investors. Lucane Pharma's commitment to addressing gaps in rare disorder treatment makes it a potential prospect for investment consideration, particularly for ventures aligned with the healthcare and pharmaceutical sectors.
There is no investment information
No recent news or press coverage available for Lucane Pharma.